{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T02:42:33Z","timestamp":1773283353784,"version":"3.50.1"},"reference-count":29,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1016\/j.ijantimicag.2012.06.003","type":"journal-article","created":{"date-parts":[[2012,7,24]],"date-time":"2012-07-24T04:16:28Z","timestamp":1343103388000},"page":"332-336","source":"Crossref","is-referenced-by-count":45,"title":["Efficacy of tigecycline\/colistin combination in a pneumonia model caused by extensively drug-resistant Acinetobacter baumannii"],"prefix":"10.1016","volume":"40","author":[{"given":"Esmeray","family":"Mutlu Yilmaz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mustafa","family":"Sunbul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdurrahman","family":"Aksoy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hava","family":"Yilmaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akif Koray","family":"Guney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tolga","family":"Guvenc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2012.06.003_bib0005","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ijantimicag.2008.07.008","article-title":"Efficacy of monotherapy and combined antibiotic therapy for carbapenem-resistant Acinetobacter baumannii pneumonia in an immunosuppressed mouse model","volume":"33","author":"Song","year":"2009","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2012.06.003_bib0010","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1128\/AAC.46.6.1946-1952.2002","article-title":"Efficacy of colistin versus \u03b2-lactams, aminoglycosides, and rifampin as monotherapy in a mouse model of pneumonia caused by multiresistant Acinetobacter baumannii","volume":"46","author":"Montero","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2012.06.003_bib0015","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1345\/aph.1D592","article-title":"Multidrug-resistant Acinetobacter infections: an emerging challenge to clinicians","volume":"38","author":"Jain","year":"2004","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.ijantimicag.2012.06.003_bib0020","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","article-title":"Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance","volume":"18","author":"Magiorakos","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2012.06.003_bib0025","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1093\/jac\/dki477","article-title":"In vitro antibacterial activities of tigecycline in combination with other antimicrobial agents determined by chequerboard and time\u2013kill kinetic analysis","volume":"57","author":"Petersen","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2012.06.003_bib0030","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1093\/jac\/dkm136","article-title":"In vitro activities of carbapenem\/sulbactam combination, colistin, colistin\/rifampicin combination and tigecycline against carbapenem-resistant Acinetobacter baumannii","volume":"60","author":"Song","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2012.06.003_bib0035","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1111\/j.1469-0691.2008.02061.x","article-title":"Colistin monotherapy vs. combination therapy: evidence from microbiological, animal and clinical studies","volume":"14","author":"Petrosillo","year":"2008","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2012.06.003_bib0040","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1093\/jac\/dkh485","article-title":"Antibiotic combinations for serious infections caused by carbapenem-resistant Acinetobacter baumannii in a mouse pneumonia model","volume":"54","author":"Montero","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2012.06.003_bib0045","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1093\/jac\/dkm178","article-title":"In vitro effect of minocycline and colistin combinations on imipenem-resistant Acinetobacter baumannii clinical isolates","volume":"60","author":"Tan","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2012.06.003_bib0050","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1097\/01.qco.0000185985.64759.41","article-title":"Treatment of multidrug resistant Acinetobacter","volume":"18","author":"Murray","year":"2005","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2012.06.003_bib0055","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1128\/AAC.01099-06","article-title":"In vitro activities of various antimicrobials alone and in combination with tigecycline against carbapenem-intermediate or -resistant Acinetobacter baumannii","volume":"51","author":"Scheetz","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2012.06.003_bib0060","unstructured":"Clinical and Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard. 8th ed. Document M07-A8. Wayne, PA: CLSI; 2009."},{"key":"10.1016\/j.ijantimicag.2012.06.003_bib0065","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0732-8893(00)00163-2","article-title":"Evaluation of antibiotic synergy against Acinetobacter baumannii: a comparison with Etest, time\u2013kill, and checkerboard methods","volume":"38","author":"Bonapace","year":"2000","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2012.06.003_bib0070","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1093\/jac\/dkp056","article-title":"Pharmacodynamic evaluation of tigecycline against Acinetobacter baumannii in a murine pneumonia model","volume":"63","author":"Koomanachai","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2012.06.003_bib0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2008.11.006","article-title":"Tigecycline in combination with other antimicrobials: a review of in vitro, animal and case report studies","volume":"34","author":"Entenza","year":"2009","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2012.06.003_bib0080","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.1128\/AAC.01581-07","article-title":"In vitro activity of tigecycline against multidrug-resistant Acinetobacter baumannii and selection of tigecycline\u2013amikacin synergy","volume":"52","author":"Moland","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2012.06.003_bib0085","doi-asserted-by":"crossref","first-page":"3577","DOI":"10.1128\/IAI.00269-08","article-title":"Rat pneumonia and soft-tissue infection models for the study of Acinetobacter baumannii biology","volume":"76","author":"Russo","year":"2008","journal-title":"Infect Immun"},{"key":"10.1016\/j.ijantimicag.2012.06.003_bib0090","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1128\/AAC.41.2.345","article-title":"Use of a new mouse model of Acinetobacter baumannii pneumonia to evaluate the postantibiotic effect of imipenem","volume":"41","author":"Joly-Guillou","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2012.06.003_bib0095","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/j.1469-0691.2005.01095.x","article-title":"Pharmacokinetic\/pharmacodynamic assessment of the in vivo efficacy of imipenem alone or in combination with amikacin for the treatment of experimental multiresistant Acinetobacter baumannii pneumonia","volume":"11","author":"Bernabeu-Wittel","year":"2005","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2012.06.003_bib0100","unstructured":"National Committee for Clinical Laboratory Standards. Methods for determining bactericidal activity of antimicrobial agents; tentative guideline. Document M26-T. Villanova, PA: NCCLS; 1992."},{"key":"10.1016\/j.ijantimicag.2012.06.003_bib0105","doi-asserted-by":"crossref","first-page":"3430","DOI":"10.1128\/AAC.01361-08","article-title":"Population pharmacokinetic analysis of colistin methanesulfonate and colistin after intravenous administration in critically ill patients with infections caused by Gram-negative bacteria","volume":"53","author":"Plachouras","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2012.06.003_bib0110","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1378\/chest.10-0463","article-title":"Steady-state pharmacokinetics and BAL concentration of colistin in critically ill patients after IV colistin methanesulfonate administration","volume":"138","author":"Imberti","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.ijantimicag.2012.06.003_bib0115","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1378\/chest.10-1860","article-title":"Colistin penetration in the alveolar lining fluid of critically ill patients treated with IV colistimethate sodium","volume":"139","author":"Markou","year":"2011","journal-title":"Chest"},{"key":"10.1016\/j.ijantimicag.2012.06.003_bib0120","doi-asserted-by":"crossref","first-page":"2946","DOI":"10.1128\/AAC.00103-06","article-title":"Heteroresistance to colistin in multidrug-resistant Acinetobacter baumannii","volume":"50","author":"Li","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2012.06.003_bib0125","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s10096-006-0123-1","article-title":"Successful treatment of septic shock due to pan-resistant Acinetobacter baumannii using combined antimicrobial therapy including tigecycline","volume":"25","author":"Taccone","year":"2006","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2012.06.003_bib0130","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1093\/cid\/cir611","article-title":"Incidence of and risk factors for colistin-associated nephrotoxicity in a large academic health system","volume":"53","author":"Pouge","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2012.06.003_bib0135","unstructured":"World Health Organization. Anti-tuberculosis drug resistance in the world. Report no. 2: prevalence and trends. Geneva, Switzerland: WHO; 2000. WHO\/CDS\/TB\/2000.278."},{"key":"10.1016\/j.ijantimicag.2012.06.003_bib0140","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1183\/09031936.00156906","article-title":"Ventilator-associated pneumonia due to colistin susceptible-only microorganisms","volume":"30","author":"Rios","year":"2007","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ijantimicag.2012.06.003_bib0145","doi-asserted-by":"crossref","first-page":"e29446","DOI":"10.1371\/journal.pone.0029446","article-title":"Active and passive immunization protects against lethal, extreme drug-resistant Acinetobacter baumannii infection","volume":"7","author":"Luo","year":"2012","journal-title":"PLoS One"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857912002579?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857912002579?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T12:10:51Z","timestamp":1561983051000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857912002579"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["S0924857912002579"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2012.06.003","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10]]}}}